EDWARD MAHAN: Open Payments
NPI 1790800472 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,550 in 67 payments from 17 companies in 2025. Trend: 2023 $2,015 · 2024 $1,212 · 2025 $1,550
Food & beverage: $1,550
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 11 | $311 |
| GlaxoSmithKline, LLC. | 13 | $219 |
| Regeneron Healthcare Solutions, Inc. | 8 | $195 |
| Grifols USA, LLC | 7 | $142 |
| GENZYME CORPORATION | 4 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Viatris Specialty LLC | 3 | $71 |
| HARMONY BIOSCIENCES LLC | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $54 |
Products named: DUPIXENT, Ohtuvayre, NUCALA, TRELEGY ELLIPTA, Prolastin-C Liquid, GLASSIA, YUPELRI, WAKIX.
Industry payments across GA — which companies pay providers there.
